{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:59:00Z","timestamp":1794293940276,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Up to 85% of people with motor neuron disease (MND) report pain, but whether pain has negative impact on quality of life is unclear. The aim was to study associations between pain, disease severity and individual quality of life (IQOL) in patients with MND.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this cross sectional study, 61 patients were recruited from four multidisciplinary teams in Sweden, whereof 55 responded to the pain measure (The Brief Pain Inventory \u2013 Short form) and were included in the main analyses. Disease severity was measured with the Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised Version, and individual quality of life was measured with a study-specific version of the Schedule for the Evaluation of Individual Quality of Life - Direct Weighting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-one (74%) of the participants who answered BPI-SF (<jats:italic>n<\/jats:italic>\u2009=\u200955) reported pain. Thirty-nine (71%) of those reported pain during the past 24\u2009h. The severity of pain was on average moderate, with eight participants (14%) reporting severe pain (PSI\u2009\u2265\u20097).<\/jats:p><jats:p>Satisfaction with IQOL for the entire sample was good (scale 1-7, where 1 equals poor quality of life): median 5, interquartile range (IQR) 2.75 and there was no difference in satisfaction with IQOL between those reporting pain\/not reporting pain (median 5, IQR 2\/median 5, IQR 3.5, Mann-Whitney U\u2009=\u2009249,<jats:italic>p<\/jats:italic>\u2009=\u20090.452). There was neither any correlation between pain severity and satisfaction with IQOL, nor between disease severity and satisfaction with IQOL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The results add to the hypothesis that associations between non-motor symptoms such as pain prevalence and pain severity and IQOL in MND are weak. Pain prevalence was high and the results pointed to that some participants experienced high pain severity, which indicate that pain assessments and pain treatments tailored to the specific needs of the MND population should be developed and scientifically evaluated.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12904-021-00848-6","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T12:10:11Z","timestamp":1634040611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Ylva","family":"\u00c5kerblom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta Jakobsson","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Nyholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingela","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"\u00c5senl\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"5 Peripheral Ne","key":"848_CR1","first-page":"1185","volume":"20","author":"E Tiryaki","year":"2014","unstructured":"Tiryaki E, Horak HA. ALS and other motor neuron diseases. Continuum (Minneapolis, Minn). 2014;20(5 Peripheral Nervous System Disorders):1185\u2013207.","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"1","key":"848_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ejp.1091","volume":"22","author":"LCG Lopes","year":"2018","unstructured":"Lopes LCG, Galhardoni R, Silva V, Jorge FMH, Yeng LT, Callegaro D, et al. Beyond weakness: characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: a controlled study. Eur J Pain. 2018;22(1):72\u201383.","journal-title":"Eur J Pain"},{"issue":"1-2","key":"848_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000493386","volume":"52","author":"G Logroscino","year":"2019","unstructured":"Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52(1-2):93\u2013103.","journal-title":"Neuroepidemiology"},{"issue":"3","key":"848_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.7861\/clinmedicine.10-3-252","volume":"10","author":"C Wood-Allum","year":"2010","unstructured":"Wood-Allum C, Shaw PJ. Motor neurone disease: a practical update on diagnosis and management. Clin Med. 2010;10(3):252\u20138.","journal-title":"Clin Med"},{"issue":"4","key":"848_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ncl.2015.07.007","volume":"33","author":"JM Statland","year":"2015","unstructured":"Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol Clin. 2015;33(4):749\u201360.","journal-title":"Neurol Clin"},{"issue":"2","key":"848_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0885-3924(02)00440-2","volume":"24","author":"C Sepulveda","year":"2002","unstructured":"Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the World Health Organization\u2019s global perspective. J Pain Symptom Manag. 2002;24(2):91\u20136.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"848_CR7","doi-asserted-by":"publisher","first-page":"e00296","DOI":"10.1002\/brb3.296","volume":"5","author":"F Hanisch","year":"2015","unstructured":"Hanisch F, Skudlarek A, Berndt J, Kornhuber ME. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5(3):e00296.","journal-title":"Brain Behav"},{"issue":"4","key":"848_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1468-1331.2011.03540.x","volume":"19","author":"A Chio","year":"2012","unstructured":"Chio A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012;19(4):551\u20135.","journal-title":"Eur J Neurol"},{"issue":"1-2","key":"848_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/21678421.2015.1074701","volume":"17","author":"HE Stephens","year":"2015","unstructured":"Stephens HE, Lehman E, Raheja D, Yang C, Walsh S, McArthur DB, et al. Pain in amyotrophic lateral sclerosis: patient and physician perspectives and practices. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):21\u20139.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7-8","key":"848_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/21678421.2014.951944","volume":"15","author":"VC Wallace","year":"2014","unstructured":"Wallace VC, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7-8):520\u20137.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"848_CR11","first-page":"115","volume":"28","author":"A Pizzimenti","year":"2013","unstructured":"Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28(2):115\u20139.","journal-title":"Funct Neurol"},{"issue":"5-6","key":"848_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/21678421.2012.751614","volume":"14","author":"I Rivera","year":"2013","unstructured":"Rivera I, Ajroud-Driss S, Casey P, Heller S, Allen J, Siddique T, et al. Prevalence and characteristics of pain in early and late stages of ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5-6):369\u201372.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"848_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JND-180322","volume":"5","author":"P Sandstedt","year":"2018","unstructured":"Sandstedt P, Littorin S, Johansson S, Gottberg K, Ytterberg C, Kierkegaard M. Disability and contextual factors in patients with amyotrophic lateral sclerosis - a three-year observational study. J Neuromuscul Dis. 2018;5(4):439\u201349.","journal-title":"J Neuromuscul Dis"},{"key":"848_CR14","volume-title":"Cancer control: knowledge into action : WHO guide for effective programmes","author":"World Health O","year":"2006","unstructured":"World Health O. Cancer control: knowledge into action : WHO guide for effective programmes. Geneva: WHO; 2006."},{"key":"848_CR15","doi-asserted-by":"publisher","unstructured":"Brettschneider J, Kurent J, Ludolph A. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2008;(3):CD005226. https:\/\/doi.org\/10.1002\/14651858.CD005226.pub2.","DOI":"10.1002\/14651858.CD005226.pub2"},{"key":"848_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874205X01610010059","volume":"10","author":"A Maggiani","year":"2016","unstructured":"Maggiani A, Tremolizzo L, Della Valentina A, Mapelli L, Sosio S, Milano V, et al. Osteopathic manual treatment for amyotrophic lateral sclerosis: a feasibility pilot study. Open Neurol J. 2016;10:59\u201366.","journal-title":"Open Neurol J"},{"key":"848_CR17","doi-asserted-by":"publisher","unstructured":"Green S, Buchbinder R, Hetrick S. Physiotherapy interventions for shoulder pain. Cochrane Database Syst Rev. 2003;(2):CD004258. https:\/\/doi.org\/10.1002\/14651858.CD004258.","DOI":"10.1002\/14651858.CD004258"},{"key":"848_CR18","doi-asserted-by":"publisher","unstructured":"Green S, Buchbinder R, Hetrick S. Acupuncture for shoulder pain. Cochrane Database Syst Rev. 2005;(2):CD005319. https:\/\/doi.org\/10.1002\/14651858.CD005319.","DOI":"10.1002\/14651858.CD005319"},{"issue":"2","key":"848_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1474-4422(16)30358-1","volume":"16","author":"A Chio","year":"2017","unstructured":"Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144\u201357.","journal-title":"Lancet Neurol"},{"issue":"13","key":"848_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJM199603283341306","volume":"334","author":"MA Testa","year":"1996","unstructured":"Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"848_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13311-014-0322-x","volume":"12","author":"Z Simmons","year":"2015","unstructured":"Simmons Z. Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics. 2015;12(2):394\u2013402.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"848_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"key":"848_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2018.12.035","volume":"397","author":"T Prell","year":"2019","unstructured":"Prell T, Gaur N, Stubendorff B, Rodiger A, Witte OW, Grosskreutz J. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. J Neurol Sci. 2019;397:92\u20135.","journal-title":"J Neurol Sci"},{"key":"848_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jns.2016.09.034","volume":"370","author":"P Sandstedt","year":"2016","unstructured":"Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269\u201373.","journal-title":"J Neurol Sci"},{"issue":"1","key":"848_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mus.23245","volume":"46","author":"TM Burns","year":"2012","unstructured":"Burns TM, Graham CD, Rose MR, Simmons Z. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012;46(1):9\u201325.","journal-title":"Muscle Nerve"},{"issue":"7048","key":"848_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/bmj.313.7048.29","volume":"313","author":"AM Hickey","year":"1996","unstructured":"Hickey AM, Bury G, O\u2019Boyle CA, Bradley F, O\u2019Kelly FD, Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV\/AIDS. BMJ. 1996;313(7048):29\u201333.","journal-title":"BMJ"},{"issue":"11","key":"848_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1136\/jnnp.2003.033100","volume":"75","author":"A Chio","year":"2004","unstructured":"Chio A, Gauthier A, Montuschi A, Calvo A, Di Vito N, Ghiglione P, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry. 2004;75(11):1597\u2013601.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"848_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/146608202760834120","volume":"3","author":"LH Goldstein","year":"2002","unstructured":"Goldstein LH, Atkins L, Leigh PN. Correlates of quality of life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(3):123\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"5-6","key":"848_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/17482960802444840","volume":"10","author":"SH Felgoise","year":"2009","unstructured":"Felgoise SH, Stewart JL, Bremer BA, Walsh SM, Bromberg MB, Simmons Z. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations. Amyotroph Lateral Scler. 2009;10(5-6):456\u201362.","journal-title":"Amyotroph Lateral Scler"},{"issue":"6","key":"848_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/ane.12774","volume":"136","author":"B Jakobsson Larsson","year":"2017","unstructured":"Jakobsson Larsson B, Ozanne AG, Nordin K, Nygren I. A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136(6):631\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"848_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1017\/S1478951509990733","volume":"8","author":"AG Olsson","year":"2010","unstructured":"Olsson AG, Markhede I, Strang S, Persson LI. Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care. 2010;8(1):75\u201382.","journal-title":"Palliat Support Care"},{"issue":"4","key":"848_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/jpm.2004.7.551","volume":"7","author":"C Neudert","year":"2004","unstructured":"Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7(4):551\u20137.","journal-title":"J Palliat Med"},{"issue":"5","key":"848_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/13548506.2011.651149","volume":"17","author":"F Tramonti","year":"2012","unstructured":"Tramonti F, Bongioanni P, Di Bernardo C, Davitti S, Rossi B. Quality of life of patients with amyotrophic lateral sclerosis. Psychol Health Med. 2012;17(5):621\u20138.","journal-title":"Psychol Health Med"},{"issue":"7","key":"848_CR34","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.52.7.1434","volume":"52","author":"L Ganzini","year":"1999","unstructured":"Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52(7):1434\u201340.","journal-title":"Neurology"},{"issue":"5","key":"848_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.neurol.2017.03.019","volume":"173","author":"G Querin","year":"2017","unstructured":"Querin G, Soraru G, Pradat PF. Kennedy disease (X-linked recessive bulbospinal neuronopathy): a comprehensive review from pathophysiology to therapy. Rev Neurol (Paris). 2017;173(5):326\u201337.","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"848_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1023\/A:1025024008139","volume":"12","author":"L Wettergren","year":"2003","unstructured":"Wettergren L, Bjorkholm M, Axdorph U, Bowling A, Langius-Eklof A. Individual quality of life in long-term survivors of Hodgkin\u2019s lymphoma--a comparative study. Qual Life Res. 2003;12(5):545\u201354.","journal-title":"Qual Life Res"},{"issue":"10","key":"848_CR37","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s11136-005-8165-x","volume":"14","author":"L Wettergren","year":"2005","unstructured":"Wettergren L, Bjorkholm M, Langius-Eklof A. Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma\u2019 survivors. Qual Life Res. 2005;14(10):2329\u201333.","journal-title":"Qual Life Res"},{"issue":"6","key":"848_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11136-009-9490-2","volume":"18","author":"L Wettergren","year":"2009","unstructured":"Wettergren L, Kettis-Lindblad A, Sprangers M, Ring L. The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW. Qual Life Res. 2009;18(6):737\u201346.","journal-title":"Qual Life Res"},{"issue":"7","key":"848_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s004150170140","volume":"248","author":"C Neudert","year":"2001","unstructured":"Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612\u20136.","journal-title":"J Neurol"},{"issue":"2","key":"848_CR40","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap"},{"key":"848_CR41","unstructured":"Cleeland CS. The brief pain inventory: user guide. Houston; 2009. Available from: https:\/\/www.mdanderson.org\/documents\/...\/BPI_UserGuide.pdf. Cited 21 Aug 2017."},{"issue":"2","key":"848_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","volume":"149","author":"DL Hoffman","year":"2010","unstructured":"Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain. 2010;149(2):194\u2013201.","journal-title":"Pain"},{"issue":"7","key":"848_CR43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/papr.12219","volume":"15","author":"J de Andres Ares","year":"2015","unstructured":"de Andres Ares J, Cruces Prado LM, Canos Verdecho MA, Penide Villanueva L, Del Valle Hoyos M, Herdman M, et al. Validation of the short form of the brief pain inventory (BPI-SF) in Spanish patients with non-cancer-related pain. Pain Pract. 2015;15(7):643\u201353.","journal-title":"Pain Pract"},{"issue":"13","key":"848_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/0961203315588972","volume":"24","author":"AN Naegeli","year":"2015","unstructured":"Naegeli AN, Tomaszewski EL, Al Sawah S. Psychometric validation of the brief pain inventory-short form in patients with systemic lupus erythematosus in the United States. Lupus. 2015;24(13):1377\u201383.","journal-title":"Lupus"},{"issue":"2","key":"848_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/BMR-160738","volume":"30","author":"EC Celik","year":"2017","unstructured":"Celik EC, Yalcinkaya EY, Atamaz F, Karatas M, Ones K, Sezer T, et al. Validity and reliability of a Turkish brief pain inventory short form when used to evaluate musculoskeletal pain. J Back Musculoskelet Rehabil. 2017;30(2):229\u201333.","journal-title":"J Back Musculoskelet Rehabil"},{"issue":"4","key":"848_CR46","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.pmr.2005.08.015","volume":"16","author":"AJ Hoffman","year":"2005","unstructured":"Hoffman AJ, Jensen MP, Abresch RT, Carter GT. Chronic pain in persons with neuromuscular disease. Phys Med Rehabil Clin N Am. 2005;16(4):1099\u2013112 xii.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1-2","key":"848_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1-2):13\u201321.","journal-title":"J Neurol Sci"},{"issue":"3","key":"848_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108(3):248\u201357.","journal-title":"Pain"},{"issue":"4","key":"848_CR49","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.pain.2010.11.019","volume":"152","author":"H Hallstr\u00f6m","year":"2011","unstructured":"Hallstr\u00f6m H, Norrbrink C. Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury? Pain. 2011;152(4):772\u20139.","journal-title":"Pain"},{"issue":"7","key":"848_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00415-017-8538-4","volume":"264","author":"LA Bakker","year":"2017","unstructured":"Bakker LA, Schroder CD, van Es MA, Westers P, Visser-Meily JMA, van den Berg LH. Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model. J Neurol. 2017;264(7):1413\u201320.","journal-title":"J Neurol"},{"key":"848_CR51","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3389\/fpsyg.2015.01197","volume":"6","author":"T Matuz","year":"2015","unstructured":"Matuz T, Birbaumer N, Hautzinger M, Kubler A. Psychosocial adjustment to ALS: a longitudinal study. Front Psychol. 2015;6:1197.","journal-title":"Front Psychol"},{"key":"848_CR52","doi-asserted-by":"crossref","unstructured":"Akerblom Y, Jakobsson Larsson B, Zetterberg L, Asenlof P. The multiple faces of pain in motor neuron disease: a qualitative study to inform pain assessment and pain management. Disabil Rehabil.\u00a02020;42(15):2123\u201332.","DOI":"10.1080\/09638288.2018.1555615"},{"issue":"5","key":"848_CR53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/1049732313480048","volume":"23","author":"M Anderson","year":"2013","unstructured":"Anderson M, Asnani M. \u201cYou just have to live with it\u201d: coping with sickle cell disease in Jamaica. Qual Health Res. 2013;23(5):655\u201364.","journal-title":"Qual Health Res"},{"issue":"12","key":"848_CR54","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/01.wnl.0000345041.83406.a2","volume":"72","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72(12):1087\u201394.","journal-title":"Neurology"},{"key":"848_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12883-015-0340-2","volume":"15","author":"S Korner","year":"2015","unstructured":"Korner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S. Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol. 2015;15:84.","journal-title":"BMC Neurol"},{"issue":"2","key":"848_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11136-009-9569-9","volume":"19","author":"EF Taminiau-Bloem","year":"2010","unstructured":"Taminiau-Bloem EF, Visser MR, Tishelman C, Koeneman MA, van Zuuren FJ, Sprangers MA. Somatically ill persons\u2019 self-nominated quality of life domains: review of the literature and guidelines for future studies. Qual Life Res. 2010;19(2):253\u201391.","journal-title":"Qual Life Res"},{"issue":"5","key":"848_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/WCO.0000000000000862","volume":"33","author":"N Pender","year":"2020","unstructured":"Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33(5):649\u201354.","journal-title":"Curr Opin Neurol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00848-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-021-00848-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00848-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T01:05:20Z","timestamp":1699664720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-021-00848-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/s12904-021-00848-6","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"11 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been performed in accordance with the Declaration of Helsinki. Study procedures adhered to guidelines for Good Clinical Practices. The study was approved by the Regional Ethics Committee in Uppsala, Sweden (approval No. 2015\/293) and the patients confirmed participation by signing an informed consent form.<b>Involving animals<\/b>Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}